Search
Certara Inc
CERTAdd to Watchlist
8.100USD
+0.320+4.11%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
LossP/E TTM
More Details of Certara Inc Company
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Certara Inc Info
Ticker SymbolCERT
Company nameCertara Inc
IPO dateDec 11, 2020
CEOFeehery (William F)
Number of employees1487
Security typeOrdinary Share
Fiscal year-endDec 11
Address4 Radnor Corporate Center, Suite 350
CityRADNOR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19087
Phone14152378272
Websitehttps://www.certara.com/
Ticker SymbolCERT
IPO dateDec 11, 2020
CEOFeehery (William F)
Company Executives of Certara Inc
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
95.37K
+51.21%
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
51.85K
+30.39%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
50.71K
+31.07%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
45.67K
+34.50%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
16.79K
+29.22%
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. James E. Cashman, III
Mr. James E. Cashman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matthew Walsh
Mr. Matthew Walsh
Independent Director
Independent Director
--
--
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
--
--
Dr. Robert P. Aspbury, Ph.D.
Dr. Robert P. Aspbury, Ph.D.
President - Certara Predictive Technologies
President - Certara Predictive Technologies
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
95.37K
+51.21%
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
51.85K
+30.39%
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
50.71K
+31.07%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
45.67K
+34.50%
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
16.79K
+29.22%
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of Certara Inc?
The top five shareholders of Certara Inc are: Mr. John E. Gallagher, III
How many institutions hold shares of Certara Inc (CERT)?
As of 2026Q1, 590 institutions hold shares of Certara Inc, with a combined market value of approximately 177.30M, accounting for 115.63% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -45999955.00.